Evolution AI offer a comprehensive solution for the extraction and structuring of data from Quarterly Reporting packages in private equity (such as ILPA reporting).
Private equity fund managers must regularly report to the regulator and their investors. Increasing levels of detail are now required in all aspects of business operations and investment performance.
Critical to an optimally effective reporting operation is high-quality data. However, generating high-quality data can represent an intense workload for teams often working under tight deadlines. Therefore, the fast and accurate extraction of data from documents such as quarterly reports and financial statements presents an ongoing challenge to PE firms.
Evolution AI offer a comprehensive solution for the extraction and structuring of data from Quarterly Reporting packages in private equity. All key datapoints can be extracted from documents in typical reporting packages (for example, according to ILPA guidelines).
Our aim is to save at least 75% of costs compared to the manual processing of documents, which we invariably achieve. Please read our client case studies to find out more.
Statements of Cash Flows
Balance Sheets
Partners' Capital Account Statement (PCAP)
Executive Summary - Firm and Fund Level Data
Calls & Distribution Notices
Statements of Cash Flows
Balance Sheets
Partners' Capital Account Statement (PCAP)
Executive Summary - Firm and Fund Level Data
Calls & Distribution Notices
99.5% or higher data accuracy guaranteed by SLA
Error and anomaly checking
Easy integration with reporting systems
Specific functionality to handle units and currency for each monetary value
Sophisticated date handling, aware of financial date periods (such as YTD and LTM)
A comprehensive QA workflow and audit log, tracking each data point to its source document
d
d
d
“When outsourcing data extraction, it’s critical to choose a solution that allows in-house staff to verify and confirm data accuracy easily. Data quality is a top priority for private markets operations, and no compromises should be made.”
- Dr Martin Goodson, Co-founder and CEO
